Does TASIMELTEON Cause Product dose omission issue? 480 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 480 reports of Product dose omission issue have been filed in association with TASIMELTEON (Tasimelteon). This represents 8.4% of all adverse event reports for TASIMELTEON.
480
Reports of Product dose omission issue with TASIMELTEON
8.4%
of all TASIMELTEON reports
0
Deaths
16
Hospitalizations
How Dangerous Is Product dose omission issue From TASIMELTEON?
Of the 480 reports, 16 (3.3%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TASIMELTEON. However, 480 reports have been filed with the FAERS database.
What Other Side Effects Does TASIMELTEON Cause?
Drug ineffective (1,632)
Insomnia (726)
Middle insomnia (412)
Somnolence (407)
Headache (381)
Nightmare (268)
Abnormal dreams (223)
Fatigue (222)
Therapeutic product effect decreased (194)
Sleep disorder (187)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which TASIMELTEON Alternatives Have Lower Product dose omission issue Risk?
TASIMELTEON vs TAVABOROLE
TASIMELTEON vs TAXOL
TASIMELTEON vs TAXOTERE
TASIMELTEON vs TAZAROTENE
TASIMELTEON vs TAZEMETOSTAT